Table 5.
The outcome of Crohn’s disease from the diagnosis of renal disease to six-month and twelve-month treatment in 20 patients with Crohn’s disease
Six-month follow-upa | Twelve-month follow-upa | ||||||
---|---|---|---|---|---|---|---|
Diagnosis | Patients (n/N) | Remissionb | Responsec | Relapsed | Remissionb | Responsec | Relapsed |
IgA nephropathy | 14/20 | 9 | 2 | 1 | 10 | 0 | 1 |
Minimal change disease | 2/20 | 2 | 0 | 0 | 1 | 1 | 0 |
Acute interstitial nephritis | 1/20 | 1 | 0 | 0 | 1 | 0 | 0 |
Granulomatous interstitial nephritis | 1/20 | 1 | 0 | 0 | 1 | 0 | 0 |
non-IgA mesangial proliferative nephritis | 1/20 | 0 | 0 | 1 | 0 | 1 | 0 |
Thin-basement-membrane nephropathy | 1/20 | 1 | 0 | 0 | 1 | 0 | 0 |
a Two and three patients were excluded due to a lack of follow-up data at six months and twelve months respectively
b Remission was defined as CDAI change from ≥ 150 or < 150 to < 150
c Response was considered to be present if CDAI decreased by 70 or more but remained ≥ 150
d Relapse was defined as CDAI change from < 150 to ≥ 150 or increased by 70 or more but remained ≥ 150